Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

A natural language processing (NLP) algorithm to identify patients with chronic cough, created and validated by Regenstrief Institute, Indiana University and Merck & Co. research scientists, is being recognized for its ingenuity and its potential.  

The paper describing the algorithm’s development, Identifying and Characterizing a Chronic Cough Cohort Through Electronic Health Records, was published in the June 2021 edition of Chest Journal, along with an editorial written by Akio Niimi, M.D., PhD. 

In the editorial, Dr. Niimi discussed the promise of the algorithm to improve chronic cough research. The condition is challenging to identify through electronic health records because it does not have an International Classification of Disease (ICD) code, therefore most indicators of the condition exist in unstructured data within the EHR. Cough is the most common complaint that leads patients to seek medical attention. Up to 40 percent of patients referred to specialist clinics do not learn the cause of their chronic cough, so this condition is an important research target.  

In the study, led by Regenstrief research scientist and IU School of Medicine professor Michael Weiner, M.D., MPH, the algorithm improved detection of chronic cough patients nearly seven-fold and created the largest chronic cough cohort ever recorded. 

Dr. Niimi states that chronic cough characterization from the EHR by NLP shows great potential as a research tool, enabling large cohort studies that were not possible before.  

Funding for this research came from Merck & Co., Inc. This is part of a partnership between Regenstrief Institute and Merck to collaborate on projects using clinical data to inform delivery of healthcare. 

Related Influence

Jun 22, 2021 • Influence
Regenstrief experts share cancer-related research as part of IU Simon Cancer Center Series
Two Regenstrief research scientists who focus on cancer research are sharing their knowledge in the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s monthly series called “Simon Says.”  The monthly virtual series was created to better connect cancer experts with the community, giving people the opportunity to hear about the latest research and ask questions.   [caption…
Continue Reading >
Jun 17, 2021 • Influence
Regenstrief CEO discusses real-world evidence and health services research at AcademyHealth conference
Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., participated in a plenary presentation on the changing nature of health-related evidence at the AcademyHealth Annual Research Meeting. He contributed to the discussion about how the addition of healthcare data and artificial intelligence is shifting the generation and application of evidence to improve health and healthcare.   The speakers examined where real-world evidence meets health services research and discussed how…
Continue Reading >